106 related articles for article (PubMed ID: 11713249)
1. Overexpression of metallothionein-II sensitizes rodent cells to apoptosis induced by DNA cross-linking agent through inhibition of NF-kappa B activation.
Papouli E; Defais M; Larminat F
J Biol Chem; 2002 Feb; 277(7):4764-9. PubMed ID: 11713249
[TBL] [Abstract][Full Text] [Related]
2. Involvement of apoptosis in mitomycin C hypersensitivity of Chinese hamster cell mutants.
Papouli E; Lafon C; Valette A; Zdzienicka MZ; Defais M; Larminat F
Biochem Pharmacol; 2000 May; 59(9):1101-7. PubMed ID: 10704939
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K
Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin.
Larminat F; Cambois G; Zdzienicka MZ; Defais M
FEBS Lett; 1998 Oct; 437(1-2):97-100. PubMed ID: 9804179
[TBL] [Abstract][Full Text] [Related]
5. A new complementation group of mitomycin C-hypersensitive Chinese hamster cell mutants that closely resembles the phenotype of fanconi anemia cells.
Telleman P; Overkamp WJ; van Wessel N; Studzian K; Wetselaar L; Natarajan AT; Zdzienicka MZ
Cancer Res; 1995 Aug; 55(15):3412-6. PubMed ID: 7614481
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity of mitomycin C-hypersensitive Chinese hamster cell mutants: a new complementation group with chromosomal instability.
Overkamp WJ; Rooimans MA; Neuteboom I; Telleman P; Arwert F; Zdzienicka MZ
Somat Cell Mol Genet; 1993 Sep; 19(5):431-7. PubMed ID: 8291021
[TBL] [Abstract][Full Text] [Related]
7. Role of GRP58 in mitomycin C-induced DNA cross-linking.
Celli CM; Jaiswal AK
Cancer Res; 2003 Sep; 63(18):6016-25. PubMed ID: 14522930
[TBL] [Abstract][Full Text] [Related]
8. The Chinese hamster V79 cell mutant V-H4 is phenotypically like Fanconi anemia cells.
Zdzienicka MZ; Arwert F; Neuteboom I; Rooimans M; Simons JW
Somat Cell Mol Genet; 1990 Nov; 16(6):575-81. PubMed ID: 2267631
[TBL] [Abstract][Full Text] [Related]
9. Basal and zinc-induced metallothionein in resistance to cadmium, cisplatin, zinc, and tertbutyl hydroperoxide: studies using MT knockout and antisense-downregulated MT in mammalian cells.
Kennette W; Collins OM; Zalups RK; Koropatnick J
Toxicol Sci; 2005 Dec; 88(2):602-13. PubMed ID: 16150881
[TBL] [Abstract][Full Text] [Related]
10. Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination.
Keller KL; Overbeck-Carrick TL; Beck DJ
Mutat Res; 2001 Jun; 486(1):21-9. PubMed ID: 11356333
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
[TBL] [Abstract][Full Text] [Related]
12. Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression.
Wu ZZ; Chow KP; Kuo TC; Chang YS; Chao CC
Biochem Pharmacol; 2011 Dec; 82(12):1860-72. PubMed ID: 21945668
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the participation of topoisomerases I and II in cadmium-induced metallothionein expression in Chinese hamster ovary cells.
Mattern MR; Tan KB; Zimmerman JP; Mong SM; Bartus JO; Hofmann GA; Drake FH; Johnson RK; Crooke ST; Mirabelli CK
Anticancer Drug Des; 1989 Aug; 4(2):107-24. PubMed ID: 2478139
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity to mitomycin C between human RSa cell line and its derivative UVr-1.
Hiwasa T; Chen Z; Nomura J; Yamamori H; Tashiro T; Nakajima N; Suzuki N
Anticancer Res; 1999; 19(5B):3915-20. PubMed ID: 10628331
[TBL] [Abstract][Full Text] [Related]
15. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response.
Abdel-Mageed AB; Agrawal KC
Cancer Res; 1998 Jun; 58(11):2335-8. PubMed ID: 9622069
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin-like domains required for glucose regulatory protein 58 mediated reductive activation of mitomycin C leading to DNA cross-linking.
Adikesavan AK; Jaiswal AK
Mol Cancer Ther; 2007 Oct; 6(10):2719-27. PubMed ID: 17938265
[TBL] [Abstract][Full Text] [Related]
18. DNA interstrand crosslinking agents and human ocular fibroblasts: differential sensitivity to mitomycin-C and cis-diaminedichloroplatinum(II).
Nakamura M; Yamamoto M
Exp Eye Res; 1994 Jul; 59(1):53-62. PubMed ID: 7835398
[TBL] [Abstract][Full Text] [Related]
19. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.
Crowley-Weber CL; Payne CM; Gleason-Guzman M; Watts GS; Futscher B; Waltmire CN; Crowley C; Dvorakova K; Bernstein C; Craven M; Garewal H; Bernstein H
Carcinogenesis; 2002 Dec; 23(12):2063-80. PubMed ID: 12507930
[TBL] [Abstract][Full Text] [Related]
20. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
